Insights from mouse models of heparin-induced thrombocytopenia and thrombosis

Current Opinion in Hematology

Volumn 9, Issue 5, 2002, Pages 395-400

  Reilly, Michael P ^a   McKenzie, Steven E ^a  

^a THOMAS JEFFERSON UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; THROMBOCYTE FACTOR 4; FC RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY DEPENDENT LYMPHOCYTOTOXICITY; ANTIGEN RECOGNITION; CLINICAL FEATURE; COMPLEX FORMATION; CONTROLLED STUDY; ENDOTHELIUM CELL; GENE DELETION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTOPENIA; THROMBOSIS; ANIMAL; ANTIBODY PRODUCTION; CHEMICALLY INDUCED DISORDER; IMMUNOLOGY; PHYSIOLOGY;

ANIMALS; ANTIBODY FORMATION; HEPARIN; MICE; MODELS, ANIMAL; PLATELET FACTOR 4; RECEPTORS, FC; THROMBOCYTOPENIA; THROMBOSIS;

EID: 0036344835     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-200209000-00002     Document Type: Review

References (51)

1. An update on heparins at the beginning of the new millennium
2. Heparin-associated thrombocytopenia: A critical review and pooled analysis
3. Heparin-induced thrombocytopenia and thrombosis
4. Heparin-induced thrombocytopenia: A ten-year retrospective
5. Heparin-induced thrombocytopenia and the clinical use of low molecular weight heparins in acute coronary syndromes
6. Heparin-induced thrombocytopenia in patients treated with low-molecular-weight heparin or unfractionated heparin
7. Treatment of heparin-induced thrombocytopenia
8. Platelet factor 4 complexed to heparin is the target for antibodies generated in heparin-induced thrombocytopenia
9. Decision analysis for use of platelet aggregation test, carbon 14-serotonin release assay, and heparin-platelet factor 4 enzyme-linked immunosorbent assay for diagnosis of heparin-induced thrombocytopenia
10. Heparin-associated thrombocytopenia: Isolation of the antibody and characterization of a multimolecular PF4-heparin complex as the major antigen
11. Comparison of PF4/heparin ELISA assay with the 14C-serotonin release assay in the diagnosis of heparin-induced thrombocytopenia
12. Heparin-induced thrombocytopenia: Natural history, diagnosis, and management
13. Heparin induced thrombocytopenia thrombosis (HIT/T) syndrome: Diagnosis and treatment
14. Fundamental concepts in the pathobiology of heparin-induced thrombocytopenia
15. Pathophysiology of heparin-induced thrombocytopenia. Clinical and diagnostic implications - A review
16. Immunoglobulin G from patients with heparin-induced thrombocytopenia binds to a complex of heparin and platelet factor 4
17. Platelet binding of IgG from patients with heparin-induced thrombocytopenia
18. Heparin-induced thrombocytopenia: New evidence for the dynamic binding of purified anti-PF4-heparin antibodies to platelets and the resultant platelet activation
19. Heparin-induced thrombocytopenia: Laboratory studies
20. Heparin-associated thrombocytopenia
21. Sera from patients with heparin-induced thrombocytopenia generate platelet-derived microparticles with procoagulant activity: An explanation for the thrombotic complications of heparin-induced thrombocytopenia
22. Characterization of the humoral immune response in heparin-induced thrombocytopenia
23. Heparin-induced thrombocytopenia: Molecular pathogenesis
24. Antibodies from patients with heparin-induced thrombocytopenia/thrombosis recognize different epitopes on heparin: Platelet factor 4
25. Defining an antigenic epitope on platelet factor 4 associated with heparin-induced thrombocytopenia
26. Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies
27. Defining a second epitope for heparin-induced thrombocytopenia/thrombosis antibodies using KKO, a murine HIT-like monoclonal antibody
28. Delayed-onset heparin-induced thrombocytopenia and thrombosis
29. Temporal aspects of heparin-induced thrombocytopenia
30. Pathogenicity of human anti-platelet factor 4 (PF4)/heparin in vivo: Generation of mouse anti-PF4/heparin and induction of thrombocytopenia by heparin
31. A mouse model for heparin-induced thrombocytopenia
32. Fc gamma RIIA H/R 131 polymerphism, subclass-specific IgG anti-heparin/platelet factor 4 antibodies and clinical course in patients with heparin-induced thrombocytopenia and thrombosis
33. Organization of the human and mouse low-affinity Fc gamma R genes: Duplication and recombination
34. A novel anti-platelet monoclonal antibody induces mouse platelet aggregation through an Fc receptor-independent mechanism
35. Biological advances and clinical applications of Fc receptors for IgG
36. Fc gamma receptors in phagocytes
37. The role of the human Fc receptor Fc gamma RIIA in the immune clearance of platelets: A transgenic mouse model
38. Localization of distal regulatory domains in the megakaryocyte-specific platelet basic protein (PBP)/platelet factor 4 (PF4) gene locus
39. The role of platelet factor 4 in platelet aggregation induced by the antibodies implicated in heparin-induced thrombocytopenia
40. Heparin-induced thrombocytopenia/thrombosis in a transgenic mouse model requires human platelet factor 4 and platelet activation through FcγRIIA
41. Immune endothelial-cell injury in heparin-associated thrombocytopenia
42. Cell biology of tissue factor, the principal initiator of blood coagulation
43. Tissue factor: A complex biologic role
44. Induction of monocyte tissue factor expression by antibodies to heparin-platelet factor 4 complexes developed in heparin-induced thrombocytopenia
45. Antibodies from patients with heparin-induced thromboctopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8
46. A new approach in the study of the molecular and cellular events implicated in heparin-induced thrombocytopenia. Formation of leukocyte-platelet aggregates
47. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets
48. Increased endothelial and platelet soluble selectins in heparin-induced thrombocytopenia associated with thrombosis
49. Anti-platelet factor 4/heparin antibodies from patients with heparin-induced thrombocytopenia provoke direct activation of microvascular endothelial cells
50. Thrombosis and shock induced by activating antiplatelet antibodies in human Fc gamma RIIA transgenic mice: The interplay among antibody, spleen, and Fc receptor
51. Anti-inflammatory activity of IVIG mediated through the inhibitory Fc receptor